Silly thread, owl...
I love it!
Have a good Memorial Day weekend! And, of course, remember our vets both with us and gone to their final reward.
Oh! I'm in a break-period as of today. Don't have to return to the netherworld till June 22nd.
So, hopefully, I will b able to post occasionally when the market is open. You and other longs-of-note have made good points, reilly. Glad to see the board is alive-and-well!
For what's is worth, I re-established a small position in ADXS on 5/15 at 20.30 when several upgrades when made public. I'm happy with the result so far, needless to say.
Wish I didn't have to sell a much larger position some months back, but, hey! that's the way it goes sometimes.
For those of you ONVO investors who also own ADXS, all I can say is SWEET!!!! (lol)
Here's a piece from The Street published a few minutes ago...
Yes, 96% of lung cancer patients demonstrated "local control" (meaning control of tumor in the lung) following surgery plus treatment with Cesium-131. But two other groups of lung cancer patients in the Brachytherapy study who had either surgery alone or a different form of radiation therapy demonstrated statistically equivalent rates of local control. The study authors note there were no differences in local control rates between the groups of lung cancer patients.
IsoRay also plays rope-a-dope with the five-year overall survival rate of 100% for Cesium-131 patients. The company fails to mention the comparable five-year survival rate for patients undergoing surgery alone is 98% -- a clinically meaningless difference of two percentage points. Moreover, the survival analysis is severely limited because nearly every patient in the study is censored, meaning they're lost to follow up. The study does not conclude that treatment with Cesium-131 leads to longer survival.
What more does one need?
Cesium-131 news hits. Spike up. Then nothing for months, and it sinks. Last spikes were in March and July 2014. Price sank to under $2 afterwards.
Probably happen this time too unless ISR is getting it's act together, and follows up with substantive news in the coming weeks.
" As always though, fundamentals will forever trump technical analysis ." I agree with this statement, daripley. Institutions are taking advantage of the current prices to either establish a position or add to their initial one. Corporate news (or lack thereof) is the main driverof stock prices -- especially of companies such as ONVO. TA analysis just tags along for the ride.
Thanks for info even if it's not quite complete, it shows a lot of net institutional buying.
I agree. If Trilexium is effective in other forms of cancer besides DIPG, it should be available for those cancers as well.
- DIPG cells respond to TRXE-009 in vitro
- DIPG is one of the most difficult cancers to treat
Lauren Hill led a brave fight to raise awareness of DIPG. She succumbed to this horrible disease within the last two to three weeks. Through her efforts upwards of 2 millions dollars were raised for DIPG research so a cure could be found for other children. Laura was 19. One of her other goals was to play basketball at the collegiate level, and her goal was reached last Fall. Many in the greater Cincinnati area and nationwide, for that matter, saw the game. Truly a remarkable young lady.
moo: how is that trending? up or down?
I have go to bed in a few minutes, so if you don't have time to research this tonight, I'll look it up early tomorrow morning.
btw... thanks for the raw numbers!
I took my long shares off the market just now by placing a GTC order at $7/share. Theoretically, if any of my shares are loaned to shorts, they'll have to recall them for the impending sale I just placed.
Should have done this months ago, but didn't. Any other true long should do this too. It, again, theoretically, makes it harder for brokers to locate long shares for shorting purposes.
reilly: Hopefully, we'll get the short interest figure within the next day or two. I agree. Strange that it hasn't been reported yet.
Yes, programs like this increases the awareness of the public to tissue/organ companies like ONVO. Some who watched last night's program will do some research into this nascent field, and may hit upon ONVO in the process.
I would think ONVO has to be at least one of the companies mentioned. Unfortunately, my cable package doesn't include National Geographics.
If ONVO is featured or mentioned, should help boost the pps tomorrow (which would be a hoot!).
Since your messages started to post again, I'm going to try with this message to start using my "profiteer1" handle again.
P.S. I like your little ditty...